K.k. Ueno Seiyaku Oyo Kenkyujo

Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo

R-tech Ueno, Ltd.

Hiroyoshi Osama

Ryuji Ueno

Tomio Oda

Yukihiko Mashima

Yoshihisa Oguchi

Tomihiko Tanino

Yoshiki Hiida

Tohru Hirato

The present invention provides a method for treatment of optic nerve disorder by the administration of a prostanoic acid compound in an amount effective in treatment of optic nerve disorder to a subject in need of such treatment, by which visual acuity can be recovered.

Treatment of optic nerve disorder with prostanoic acid compounds

A method of treatment for improving encephalic function which comprises administering, to a subject in need of such treatment, a 15-keto-prostaglandin compound in an amount effective for improvement of encephalic function.

Use of 15-keto-prostaglandin compound for improvement of encephalic

A method for treatment of a cardiac dysfunction which comprises administering, to a subject in need of such treatment, a 15-ketoprostaglandin compound in an amount effective in treatment of the cardiac dysfunction.

Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds

A method for treatment of a pulmonary dysfunction which comprises administering, to a subject in need of such treatment, a 15-ketoprostaglandin compound in an amount effective in treatment of the pulmonary dysfunction.

Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds

A method for treatment of hyperlipemia which comprises administering, to a subject in need of such treatment, a 15-keto-prostaglandin compound in an amount, effective in decreasing lipid concentration in the blood.

Treatment of hyperlipidemia with 15-keto-prostaglandin compounds

A method for improvement of excretion of nonprotein nitrogen into the intestines which comprises administering, to a subject in need of such improvement, a prostanoic acid derivative in an amount effective in improving excretion of nonprotein nitrogen into the intestines.

Excretion of nonprotein nitrogen into the intestine by prostanoic acid

15-keto-prostaglandin compound for improvement of encephalic function

A method for treatment of a hepatobiliary disease which comprises administering, to a subject in need of such treatment, a 15-ketoprostaglandin compound in an amount effective in treatment of the hepatobiliary disease.

Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds

Amethod for inducing decrease in potassium ion concentration in the blood which comprises administering, to a subject having an increased potassium ion concentration in the blood, a prostanoic acid derivative in an amount effective in inducing decrease in potassium ion concentration in the blood wherein said concentration is increased or for improving extracorporeal excretion of potassium ion in the blood which comprises administering, to a subject having an increased potassium ion concentration in the blood, a prostanoic acid derivative in an amount effective in improving extracorporeal excretion of potassium ion concentration is increased.

Growing community of inventors

Hyogo, Japan

Hiroyoshi Osama